Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BCD-020 vs MabThera in Rheumatoid Arthritis
NCT01759030Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Dec 2012
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of IBI301 in rheumatoid arthritis (RA), sponsored by BIOCAD. Started Dec 2012; status: completed.
02
Drugs
IBI301
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01759030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759030.